“Biomarker-Guided Drug Repurposing and Molecular Validation of Angiotensin-2 Receptor Type-1 in Brain Tumor”. Precision Medicine Communications, vol. 3, no. 1, June 2023, pp. 27-42, https://doi.org/10.55627/pmc.003.01.0296.